1. Patterns of Care for T1 Glottic Squamous Cell Carcinomas from 2004-2020.
- Author
-
Malik D, Jacobs D, Fereydooni S, Park HS, and Mehra S
- Subjects
- Humans, Male, Female, Aged, Middle Aged, United States, Practice Patterns, Physicians' statistics & numerical data, Practice Patterns, Physicians' trends, Combined Modality Therapy statistics & numerical data, Databases, Factual, Laryngectomy statistics & numerical data, Retrospective Studies, Laryngeal Neoplasms therapy, Laryngeal Neoplasms pathology, Glottis pathology, Glottis surgery, Carcinoma, Squamous Cell therapy, Carcinoma, Squamous Cell pathology, Neoplasm Staging
- Abstract
Objective(s): Describe recent national trends in overall treatment modalities for T1 glottic squamous cell carcinomas (SCC), and identify factors associated with treatment regimens., Methods: National Cancer Database from 2004-2020 was queried for all patients with glottic cT1N0M0 SCC. Treatment patterns over time were analyzed using the Cochran-Armitage test for trend. Multivariable logistic regressions were used to determine the factors associated with treatment regimens., Results: Of the 22,414 patients identified, most patients received RT only (57%), 21% received surgery only, and 22% received dual-modality treatment ("over-treatment"). Over the time period, there was a decreasing trend in rates of over-treatment for T1 glottic SCC (p < 0.001) and an increasing trend in surgery only (p < 0.001). Treatment in 2016-2018 (OR: 1.168 [1.004 to 1.359]), 2013-2015 (OR: 1.419 [1.221 to 1.648]), 2010-2012 (OR: 1.611 [1.388 to 1.871]), 2007-2009 (OR: 1.682 [1.450 to 1.951]), or 2004-2006 (OR: 1.795 [1.548 to 2.081]) versus 2019-2020 was associated with greater likelihood of over-treatment. T1b tumors were less likely to be over-treated (OR: 0.795 [0.707 to 0.894]) versus T1a tumors, and less likely to receive surgery first (OR: 0.536 [0.485 to 0.592]) versus T1a tumors., Conclusion: Over-treatment for T1 glottic SCC has been declining, with increasing rates of surgery only. Year of treatment was significantly associated with the receipt of dual-modality treatment. Finally, patients with T1b disease were more likely to receive RT as the first and only treatment., Level of Evidence: 3 Laryngoscope, 134:3633-3644, 2024., (© 2024 The American Laryngological, Rhinological and Otological Society, Inc.)
- Published
- 2024
- Full Text
- View/download PDF